These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26704203)

  • 1. Cost-Effectiveness Analysis of Deep Brain Stimulation in Patients with Parkinson's Disease in Japan.
    Kawamoto Y; Mouri M; Taira T; Iseki H; Masamune K
    World Neurosurg; 2016 May; 89():628-635.e1. PubMed ID: 26704203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease.
    Dams J; Siebert U; Bornschein B; Volkmann J; Deuschl G; Oertel WH; Dodel R; Reese JP
    Mov Disord; 2013 Jun; 28(6):763-71. PubMed ID: 23576266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of neurostimulation in Parkinson's disease with early motor complications.
    Dams J; Balzer-Geldsetzer M; Siebert U; Deuschl G; Schuepbach WM; Krack P; Timmermann L; Schnitzler A; Reese JP; Dodel R;
    Mov Disord; 2016 Aug; 31(8):1183-91. PubMed ID: 27506638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep Brain Stimulation for Parkinson's Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis.
    Fundament T; Eldridge PR; Green AL; Whone AL; Taylor RS; Williams AC; Schuepbach WM
    PLoS One; 2016; 11(7):e0159340. PubMed ID: 27441637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of subthalmic nucleus deep brain stimulation for the treatment of advanced Parkinson disease in Hong Kong: a prospective study.
    Zhu XL; Chan DT; Lau CK; Poon WS; Mok VC; Chan AY; Wong LK; Yeung JH; Leung MC; Tang VY; Wong RK; Yeung C
    World Neurosurg; 2014 Dec; 82(6):987-93. PubMed ID: 25175275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of Deep Brain Stimulation for Advanced Parkinson's Disease in the United States.
    Pietzsch JB; Garner AM; Marks WJ
    Neuromodulation; 2016 Oct; 19(7):689-697. PubMed ID: 27491661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep brain stimulation in the treatment of Parkinson's disease: a cost-effectiveness analysis.
    Tomaszewski KJ; Holloway RG
    Neurology; 2001 Aug; 57(4):663-71. PubMed ID: 11524476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson's disease.
    Eggington S; Valldeoriola F; Chaudhuri KR; Ashkan K; Annoni E; Deuschl G
    J Neurol; 2014 Jan; 261(1):106-16. PubMed ID: 24158271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic Analysis of Deep Brain Stimulation in Parkinson Disease: Systematic Review of the Literature.
    Becerra JE; Zorro O; Ruiz-Gaviria R; Castañeda-Cardona C; Otálora-Esteban M; Henao S; Navarrete S; Acevedo JC; Rosselli D
    World Neurosurg; 2016 Sep; 93():44-9. PubMed ID: 27216925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness Analysis of Deep Brain Stimulation for Parkinson Disease in Taiwan.
    Fann JC; Chang KC; Yen AM; Chen SL; Chiu SY; Chen HH; Liou HH
    World Neurosurg; 2020 Jun; 138():e459-e468. PubMed ID: 32147563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective comparative study on cost-effectiveness of subthalamic stimulation and best medical treatment in advanced Parkinson's disease.
    Valldeoriola F; Morsi O; Tolosa E; Rumià J; Martí MJ; Martínez-Martín P
    Mov Disord; 2007 Nov; 22(15):2183-91. PubMed ID: 17724747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of deep brain stimulation for the treatment of Parkinson's disease by surgical stimulation sites.
    Stroupe KT; Weaver FM; Cao L; Ippolito D; Barton BR; Burnett-Zeigler IE; Holloway RG; Vickrey BG; Simuni T; Follett KA
    Mov Disord; 2014 Nov; 29(13):1666-74. PubMed ID: 25220042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Minimization Analysis of Deep-Brain Stimulation Using National Database of Japanese Health Insurance Claims.
    Akazawa M; Konomura K; Shiroiwa T
    Neuromodulation; 2018 Aug; 21(6):548-552. PubMed ID: 29697171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-utility analysis of Parkinson's disease.
    Shan DE; Wu HC; Chan LY; Liu KD
    Acta Neurol Taiwan; 2011 Mar; 20(1):65-72. PubMed ID: 21249581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral Deep Brain Stimulation is the Procedure to Beat for Advanced Parkinson Disease: A Meta-Analytic, Cost-Effective Threshold Analysis for Focused Ultrasound.
    Mahajan UV; Ravikumar VK; Kumar KK; Ku S; Ojukwu DI; Kilbane C; Ghanouni P; Rosenow JM; Stein SC; Halpern CH
    Neurosurgery; 2021 Feb; 88(3):487-496. PubMed ID: 33295629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson's disease in the UK and Germany.
    Walter E; Odin P
    J Med Econ; 2015 Feb; 18(2):155-65. PubMed ID: 25348011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-utility analysis of deep brain stimulation surgery plus best medical therapy versus best medical therapy in patients with Parkinson's: Economic evaluation alongside the PD SURG trial.
    McIntosh E; Gray A; Daniels J; Gill S; Ives N; Jenkinson C; Mitchell R; Pall H; Patel S; Quinn N; Rick C; Wheatley K; Williams A;
    Mov Disord; 2016 Aug; 31(8):1173-82. PubMed ID: 26846185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Review of the economic evidence on the use of deep brain stimulation in late stage Parkinson's disease].
    Puig-Junoy J; Puig Peiró R
    Neurologia; 2009 May; 24(4):220-9. PubMed ID: 19603291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
    Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
    J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost analysis of awake versus asleep deep brain stimulation: a single academic health center experience.
    Jacob RL; Geddes J; McCartney S; Burchiel KJ
    J Neurosurg; 2016 May; 124(5):1517-23. PubMed ID: 26587660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.